Organ Static Cold Storage (SCS) Solution Market

Organ Static Cold Storage Solution Market Forecast and Outlook By FMI

In 2025, the global organ static cold storage solution market was valued at approximately USD 129.8 million. Based on Future Market Insights' analysis, demand for organ static cold storage solutions is estimated to grow to USD 136.3 million in 2026 and is projected to reach approximately USD 211.4 million by 2036. FMI projects a CAGR of approximately 5.0% during the forecast period.

Absolute dollar growth of over USD 81.6 million over the decade signals steady expansion driven by increasing transplant procedure volumes, wider organ procurement coordination networks, and the need for standardized preservation protocols that maintain organ viability during transport and pre-transplant holding periods. Despite emerging perfusion-based technologies gaining attention, static cold storage solutions remain the global baseline due to regulatory familiarity, operational simplicity, and established clinical evidence.

Summary of Organ Static Cold Storage Solution Market

• Organ Static Cold Storage Solution Market Definition:
  • The industry covers specialized preservation fluids used to maintain donated organs during cold storage and transport, ensuring viability for transplantation.
• Demand Drivers in the Market:
  • Global transplant procedure volumes continue to expand.
  • Organ procurement networks require standardized preservation protocols.
  • Emphasis on organ quality and cold ischemia time management.
• Key Segments Analyzed in the FMI Report:
  • Packaging Volume: 1000ml/bag leads with 48.2% share.
  • Application: Hospitals dominate at 66.0% share.
  • Geography: Asia Pacific leads growth; North America maintains largest market.
• Analyst Opinion at FMI:
  • Sabyasachi Ghosh, Principal Consultant for Healthcare at Future Market Insights, opines, "In the updated version of the Organ Static Cold Storage Solution Market Report for 2026 to 2036, transplant center administrators and procurement specialists will find insights into how formulation advancements are extending acceptable cold ischemia times and how packaging innovations are improving cold chain logistics. Besides this, my findings point at cost sensitivity in developing healthcare systems and the emergence of enhanced preservation formulations with superior cellular protection properties."
• Strategic Implications/Executive Takeaways:
  • Shift focus from commodity preservation media to application-specific solutions with documented clinical efficacy.
  • Treat regulatory approvals and quality certifications as market access requirements.
  • Prioritize partnerships with transplant centers and organ procurement organizations.
• Methodology:
  • Validated through transplant procedure statistics and manufacturer shipment data.
  • Zero reliance on speculative third-party market research reports.
  • Based on verifiable organ procurement records and clinical adoption patterns.

As Craig Marshall, CEO of OrganOx, noted regarding the urgency of global transplant demand and the company’s strategic expansion, “The global need for donor organs remains urgent, with thousands of patients each year dying while waiting for a transplant or facing the risk of a failed transplant. Our mission has always been to create a world where every organ counts. Joining Terumo will accelerate our ability to scale our operations more rapidly, enter new markets and ensure that more patients around the globe can benefit from our technologies.” [1]

China (9.3% projected) and India (8.6% projected) drive new opportunities through expanding transplant program infrastructure and comprehensive organ procurement system development. Germany (7.9% projected) and Brazil (7.2% projected) contribute via leadership in transplant medicine and healthcare modernization.

Organ Static Cold Storage Solution Market Definition

Organ static cold storage (SCS) solutions are specialized preservation fluids used to maintain donated organs (kidneys, livers, hearts, pancreata) during transportation and storage between procurement and transplantation. These solutions are designed to reduce cellular metabolism, minimize ischemic injury, and preserve organ viability by maintaining a controlled cold environment (typically 2-8°C). The solutions contain electrolytes, buffers, and impermeants to prevent cellular swelling, along with antioxidants and metabolic substrates to support cellular integrity during cold ischemia. Available in various packaging volumes (1000ml/bag, 2000ml/bag), SCS solutions are the foundational preservation technology in transplant medicine, used by hospitals, organ procurement organizations, and research institutions .

Organ Static Cold Storage Solution Market Inclusions

The report includes a comprehensive analysis of market dynamics, featuring Global and Regional Market Sizes (Volume and Value) and a 10-year Forecast (2026-2036). It covers segmental breakdowns by packaging volume (1000ml/bag, 2000ml/bag, Others), application (Hospitals, Laboratories/Research Institutes, Others), and geographic regions.

Organ Static Cold Storage Solution Market Exclusions

The scope excludes machine perfusion systems and devices, organ transport containers and cold storage equipment, and non-preservation solutions used in transplant procedures (immunosuppressants, surgical supplies).

Organ Static Cold Storage Solution Market Research Methodology

• Primary Research: Interviews were conducted with transplant surgeons, organ procurement organization directors, hospital procurement specialists, and preservation solution manufacturers across major regions. Biochemists clarified solution formulation and preservation mechanisms.
• Desk Research: Transplant procedure statistics, organ procurement data, and corporate financial filings supported volume benchmarking.
• Market-Sizing and Forecasting: A hybrid top-down and bottom-up model was developed. Demand was reconstructed from global transplant volumes, solution consumption per procedure, and regional adoption patterns, then validated against manufacturer shipment data.
• Data Validation and Update Cycle: Outputs undergo anomaly screening, variance checks across production and trade datasets, and structured peer review prior to release.

Segmental Analysis

Organ Static Cold Storage Solution Market Analysis by Packaging Volume

Based on FMI’s organ static cold storage solution market report, the 1000 mL/bag format is estimated to hold 48.2% share in 2026. Growth in demand for the 1000 mL format stems from its role as the standardized unit for single-organ flushing and hypothermic storage, aligning precisely with surgical protocols while minimizing excess medical waste and handling complexity during time-sensitive transplant procedures.

• Clinical Standardization: Bridge to Life Ltd. provides Belzer UW® Cold Storage Solution in "1,000 mL in one-liter bags" as the standard unit, ensuring compatibility with established surgical flush-out and preservation workflows [2].
• Dual-Organ Efficiency: Preservation Solutions Inc. notes that "Preservation Solutions, Inc. recommends a volume of 1000 mL of MaPerSol® perfusate (one bag) for two (2) human kidneys," supporting efficient allocation in machine-assisted or paired-organ protocols [3].
• Waste Minimization: Standardized volume packaging reduces partial-use disposal and simplifies cold-chain inventory control within hospital transplant units.

Organ Static Cold Storage Solution Market Analysis by Application

Hospitals are estimated to hold 66.0% share in 2026. This concentration reflects their position as the central node of the transplant lifecycle, managing donor stabilization, organ retrieval, preservation, and recipient implantation within tightly controlled clinical environments.

• Transplant Protocol Control: National Organ and Tissue Transplant Organization guidelines specify that the "OT (Operating Theatre) should be kept warm and warming blanket and fluid warmers should be used," while cold preservation processes are initiated immediately upon organ retrieval [4].
• Immediate Flush Requirement: According to Bridge to Life Ltd. instructions, the "cold solution is used to flush the isolated organ immediately before removal from the donor and/or immediately after removal from the donor," reinforcing hospital-centered procurement integration [5].
• Logistics Integration: Hospitals rely on preservation solutions that align seamlessly with established retrieval timelines, sterile handling protocols, and on-site surgical team coordination.

Organ Static Cold Storage Solution Market Drivers, Restraints, and Opportunities

Future Market Insights analysis that historical patterns point at a mature but essential medical technology category where static cold storage remains the global standard for organ preservation, now seeing incremental innovation in formulation chemistry and packaging while facing potential disruption from perfusion technologies. Estimated valuation in 2026 represents the "quality optimization phase" as transplant centers emphasize cold ischemia time management and organ quality metrics.

While emerging perfusion technologies pose long-term competitive pressure, the proven reliability, cost-effectiveness, and regulatory familiarity of SCS solutions ensure continued dominance for the majority of transplant procedures, resulting in steady mid-single-digit growth aligned with transplant volume expansion.

• Transplant Volume Growth: Continuous expansion of organ transplantation programs across established and emerging healthcare markets drives demand for standardized preservation solutions.
• Organ Procurement Network Development: Growing emphasis on organized procurement systems and coordinated transport logistics creates demand for reliable preservation technologies.
• Clinical Quality Focus: Increasing emphasis on transplant outcome optimization and organ quality maintenance throughout preservation periods supports adoption of advanced preservation solutions.

Regional Analysis

Based on the regional analysis, the Organ Static Cold Storage Solution Market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa across 40+ countries. The full report also offers market attractiveness analysis based on regional trends.

Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research

North America Organ Static Cold Storage Solution Market Analysis

North America remains the global leader in clinical transplant innovation, where growth is supported by the integration of advanced perfusion platforms alongside traditional static cold storage protocols. Market expansion is reinforced by structured PMA studies and scaling of organ transport systems that complement cold preservation workflows.

• United States: Demand for organ static cold storage solutions in the United States is projected to rise at 6.6% CAGR through 2036. Leading providers reported that "during 2026 we will continue to build an organization ready to deliver a full-scale product launch of XVIVO Heart Assist Transport and Kidney Assist," following a year in which "the Abdominal business area delivered sales growth in local currencies of 30 percent." [6]

FMI’s report includes detailed analysis of growth in North America, along with a country-wise assessment that includes the United States and Canada. Readers can review transplant volumes, clinical innovation trends, and hospital procurement frameworks shaping the regional market.

Asia Pacific Organ Static Cold Storage Solution Market Analysis

Asia Pacific is the fastest-growing region, driven by rapid transplant system expansion and government-backed infrastructure programs designed to stabilize organ donation and retrieval networks.

• China: Leading with a 9.3% CAGR, transplant infrastructure continues to scale. Official reporting states that "since China launched pilot programs in 2010, organ donation has developed from nonexistence into a well-established system over the past 15 years," with "11,249 organ donation cases in 2024," including "6,744 posthumous donations and 4,505 living donations from relatives." [7]
• India: Domestic demand is advancing at 8.6% CAGR, supported by infrastructure expansion. The National Organ Transplant Program networks with "857 hospitals/institutions, including 654 organ transplant centers and 132 organ retrieval centers," strengthening procurement logistics nationwide. [8]

The full report analyzes the Organ Static Cold Storage Solution Market across East and South Asia from 2021-2036, covering transplant system growth, hospital integration, and preservation protocol standardization.

Latin America Organ Static Cold Storage Solution Market Analysis

Latin America is emerging as a high-volume transplant region, supported by rising surgical activity and targeted national acceleration programs.

• Brazil: A projected 7.2% CAGR through 2036 aligns with transplant growth milestones. The country "reached a historic record for transplants performed by the Unified Health System (SUS) in 2024, with more than 30,000 procedures," though the "donation effectiveness rate (27%) was below the expected rate (30%), mainly due to high family refusal (46%)." [9]

The report provides detailed analysis for Brazil, Mexico, Argentina, Chile, Peru and the Rest of Latin America. Readers can assess transplant volumes, policy initiatives, and donor participation metrics influencing regional demand.

Europe Organ Static Cold Storage Solution Market Analysis

Europe operates within a highly regulated transplant framework, where preservation standards and cross-border coordination drive solution demand. Growth is linked to standardized procurement models and institutional reimbursement mechanisms.

• Germany: Demand in Germany is projected to rise at 7.9% CAGR through 2036. The regulatory structure mandates that "organ removal from ‘non-heart-beating donors’ is prohibited," and the DSO "reimburses the personnel and material costs which arise in the course of an organ donation," reinforcing centralized oversight. [10]
• United Kingdom: The UK market is projected to grow at 5.2% CAGR through 2036. NHS Blood and Transplant positions itself as "vital infrastructure to the NHS," calling for "systemic changes that shift the dial on reducing the organ and tissue transplant waiting list." [11]

FMI’s analysis of the European market includes country-wise assessment covering Germany, France, Italy, the United Kingdom, Spain, Nordic countries, Benelux and the Rest of Europe. Readers can evaluate regulatory structures, transplant network integration, and clinical protocol standardization shaping regional growth.

Competitive Aligners for Market Players

The Organ Static Cold Storage Solution market remains structurally fragmented at a global level, yet effective competition is concentrated among a limited group of clinically validated manufacturers capable of meeting regulatory, sterility, and distribution requirements of major transplant centers. A meaningful share of global supply is controlled by companies with vertically integrated formulation, aseptic filling, and cold-chain logistics infrastructure, while smaller regional producers operate with limited pricing leverage and high compliance dependency. Primary competitive variable is regulatory survivability and uninterrupted hospital supply, not peak margin expansion during procurement cycles.

Manufacturers with in-house sterile compounding facilities, validated GMP-compliant production lines, and established distribution agreements absorb raw material volatility and quality control costs more effectively. Suppliers dependent on third-party contract manufacturers face greater exposure to batch delays, audit risks, and margin compression. Regulatory compliance further narrows the field. The ability to consistently meet FDA, EMA, and national transplant authority standards for solution stability, endotoxin limits, and packaging integrity requires advanced quality systems and documented clinical validation, creating natural attrition among undercapitalized entrants.

Customer concentration reinforces buyer leverage. Large hospital transplant networks and national procurement bodies multi-source preservation solutions to prevent dependency, limiting price pass-through and raising qualification barriers for new suppliers.

Recent Developments

The report includes full coverage of key trends from competitive benchmarking. Some of the recent developments covered in the reports:

• In January 2026, Bridge to Life secured FDA De Novo clearance for its VitaSmart HOPE system, the first USA-approved cold machine perfusion technology for liver transplant preservation, with commercial launch planned for early 2026 [12].
• In January 2025, Paragonix announced the first-in-human use of its FDA-cleared KidneyVault portable renal perfusion system, successfully transporting four donor kidneys nationwide while maintaining continuous hypothermic perfusion and real-time monitoring [13].

Key Players in Organ Static Cold Storage Solution Market

• Organ Recovery Systems (Getinge Group)
• Preservation Solutions, Inc.
• IGL Group
• Koehler Chemie GmbH & Co. KG
• Bridge to Life Ltd.
• OrganOx Limited
• XVIVO Perfusion AB
• Vivaly (Dr. Franz Köhler Chemie GmbH)
• Paragonix Technologies, Inc.
• SALF S.p.A.
• TX Innovations B.V.
• tranSnovo GmbH
• TransMedics, Inc.
• Waters Medical Systems
• Essential Pharmaceuticals, LLC
• BioLife Solutions, Inc.
• CryoPort, Inc.
• Cell & Tissue Systems, Inc.
• Tecomed Group
• Medtronic plc

Scope of the Report

Organ Static Cold Storage Solution Market Analysis by Segments

Packaging Volume:

• 1000ml/bag
  • Single-organ preservation
  • Standard transplant protocols
• 2000ml/bag
  • Extended transport
  • Multi-organ procedures
  • Research applications
• Others
  • Specialized formats
  • Experimental protocols

Application:

• Hospitals
  • Transplant Centers
  • Surgical Departments
  • Organ Procurement Units
• Laboratories/Research Institutes
  • Preservation Research
  • Protocol Development
  • Ex Vivo Organ Assessment
• Others
  • Organ Procurement Organizations
  • Transport Services
  • Specialized Preservation Facilities

Region:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • Turkey
  • South Africa
  • Rest of Middle East & Africa

Bibliography

• OrganOx Ltd. (2025). OrganOx completes acquisition by Terumo Corporation to advance the future of organ transplantation. OrganOx.
• Bridge to Life Ltd. (2025). Belzer UW® cold storage transplant solution. Bridge to Life™.
• Preservation Solutions, Inc. (2025). MAPERSOL® preservation solutions.
• National Organ and Tissue Transplant Organization (NOTTO), Ministry of Health & Family Welfare, Government of India. (2024). Standard operating procedures for organ transplantation.
• Bridge to Life Ltd. (2025). Instructions for use: Belzer UW® cold storage solution. Bridge to Life™.
• XVIVO Perfusion AB. (2026). Year-end report 2025.
• Global Times. (2025). Over 7.3 million people recorded as registered organ donation volunteers in China.
• National Organ and Tissue Transplant Organization (NOTTO), Ministry of Health & Family Welfare, Government of India. (2024). NOTTO annual report 2023-2024.
• Brazilian Transplant Registry. (2024). Analysis of the Brazilian transplant registry 2024.
• German Reference Centre for Ethics in the Life Sciences (DRZE). (2025). Organ transplantation.
• NHS Blood and Transplant. (2025). Annual report and accounts: 2024 to 2025.
• Bridge to Life Ltd. (2025). Bridge to Life™ secures FDA De Novo clearance for VitaSmart™ hypothermic oxygenated perfusion (HOPE) system.
• Paragonix Technologies, Inc. (2025). Paragonix announces world’s first-in-human use of KidneyVault renal perfusion system.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Addresses

• Market intelligence to enable structured strategic decision-making across mature and emerging organ static cold storage solution markets
• Market size estimation and 10-year revenue forecasts from 2026 to 2036, supported by validated transplant procedure statistics and organ procurement data
• Growth opportunity mapping across packaging volumes and applications with emphasis on 1000ml/bag format and hospital applications
• Segment and regional revenue forecasts covering all major product categories and geographic regions
• Competition strategy assessment including clinical validation, regulatory approvals, and institutional relationships benchmarking
• Technology roadmap tracking including formulation advancements, packaging innovations, and preservation chemistry developments
• Regulatory impact analysis covering medical device standards, pharmaceutical regulations, and transplant quality requirements
• Market report delivery in PDF, Excel, PPT, and interactive dashboard formats for executive and operational use